Eau Thermale Avène Launches Inaugural 'National Skin Barrier Day' on March 12th

Leading the Charge in Skin Barrier Awareness

PARSIPPANY, N.J., March 12, 2025 /PRNewswire/ -- Pierre Fabre Laboratories, the world's second largest dermo-cosmetics laboratory, continues its commitment to improving the quality of life of those with sensitive skin disorders with the launch of Eau Thermale Avene's National Skin Barrier Day. This inaugural observance is dedicated to educating and empowering individuals to protect their skin's most vital defense: the skin barrier.

As the largest organ in the body, the skin acts as a primary line of defense for overall health yet properly caring for it remains largely misunderstood. With persistent skincare misconceptions, coupled with the surge in DIY trends and ingredient misuse, skin barriers are increasingly compromised, highlighting the critical need for greater education and understanding. Avène aims to spearhead this dedicated day of skin knowledge, underscoring the crucial role of the skin barrier and offering accessible, clinically proven solutions for every skin type and concern.

At the Heart of National Skin Barrier Day is Avène's Cicalfate+ Restorative Protective Cream – a dermatologist recommended multi-use solution with 45 different uses. Avene's innovative approach to this barrier cream is powered by C+ Restore, a postbiotic ingredient derived from a bacterium found in Avène's Thermal Spring Water. This, combined with the brand's Copper-Zinc Sulfate Complex, creates a soothing and protective formula that is clinically proven to restore the skin in 48 hours¹. Safe for the entire family to use, this product is designed to restore, soothe and strengthen the skin barrier.

"We feel so passionate about the importance of taking care of your skin barrier that we decided to create a day to promote awareness. As the #1 French Pharmacy derm-skincare brand, Avène is not just leading a conversation—we're changing the narrative around skin health," said Lisa Morris, President & CEO at Avène. "Our commitment is to provide effective, clinically proven solutions, paired with comprehensive education, to ensure that healthy skin is within everyone's reach."

Avène encourages its community to join the conversation by sharing their personal uses of Cicalfate+ Restorative Protective Cream with the hashtag #CicafateIt, amplifying the conversation about skin barrier health.  Whether it's sharing your favorite skin barrier care practices or consulting a dermatologist for personalized skincare advice, this day is an opportunity to take action toward healthier skin.

The Cicalfate+ Restorative Protective Cream can be purchased at Amazon, CVS, Target, Ulta and Walgreens.

For more information, follow @aveneusa on Instagram and TikTok or visit www.aveneusa.com.

Note: High-resolution images, interviews, and product samples are available upon request.

ABOUT EAU THERMALE AVÈNE
With over 275 years of expertise rooted in dermatology and hydrotherapy, Eau Thermale Avène by Pierre Fabre is a leading brand dedicated to managing sensitive skin disorders and is recommended by dermatologists worldwide. Formulated with dermatologist-grade ingredients, Avène offers a wide range of high-quality, efficacious solutions with proven results. As Pierre Fabre is dedicated to improving the quality of life for all skin types, dermatologists are involved from product concept, development, and testing, to create safe solutions for even the most sensitive skin. At the heart of every formula is Avène Thermal Spring Water, which is clinically proven to soothe, soften and calm the skin and all products are non-comedogenic.

ABOUT PIERRE FABRE LABORATORIES 
Pierre Fabre Laboratories is the world's second-largest dermo-cosmetics company and one of Europe's leading pharmaceutical companies. Its portfolio includes several international brands and medical franchises such as Pierre Fabre Oncology, Pierre Fabre Dermatologie, Pierre Fabre Pharma Care, Eau Thermale Avène, Ducray, A-Derma, Klorane, René Furterer, Darrow, Meme Cosmetics, Naturactive, Elgydium, Inava and Arthrodont. 

In 2023, Pierre Fabre Laboratories posted 2.83 billion euros in revenue, 70% of which came from international sales in 120 countries. Historically based in the southwest of France and manufacturing 95% of its products in France, Pierre Fabre Laboratories employs over 10,000 people worldwide. Its annual R&D budget amounts to nearly 200 million euros, of which about 50% is dedicated to targeted therapies in oncology and 40% to skin health and care solutions.

Pierre Fabre Laboratories' majority shareholder (86%) is the eponymous Foundation, which is recognized by the French government as being a public-interest foundation. This capital structure guarantees the company's independence and long-term vision. Dividends paid to the

Pierre Fabre Foundation enables the latter to design and finance humanitarian healthcare-access programs in developing countries. Employees are the company's secondary shareholder, through an international employee shareholding plan.

Pierre Fabre Laboratories' sustainability policy has been assessed by the independent AFNOR Certification body and has been awarded the "Exemplary" level of its CSR label (ISO 26 000 standard for sustainable development). 

¹Promotes epidermal restoration from 48h. Clinical study under dermatological, pediatric and gynecological control, 248 subjects, 2 applications per day for 21 days, clinical rating at 48 hours.

Media Contact:
Beach House PR
[email protected]

SOURCE Avène USA